Company Search:
Advanced Search
Sponsored Links
Adma Biologics Inc Company Snapshot
Adma Biologics Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Adma Biologics Inc with three other companies in this sector in the United States: Acceleron Pharma Inc (2018 sales of $13.99 million of which 100% was Bio-pharmaceutical), Biocryst Pharmaceuticals Inc ($20.65 million of which 100% was Pharmaceuticals), and Champions Oncology Inc ($20.24 million ).

Sales Analysis. Adma Biologics Inc reported sales of $16.99 million for the year ending December of 2018. This represents a sharp decrease of 25.4% versus 2017, when the company's sales were $22.76 million. Contributing to the drop in overall sales was the 38.1% decline in Adma Bio Manufacturing, from $10.98 million to $6.80 million. There were also decreases in sales in Plasma Collection Center (down 13.7% to $10.04 million) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Adma Biologics Inc
  Stock Performance Chart for Adma Biologics Inc
  Stock Data: Recent Stock Performance:
  Current Price (2/21/2020): 3.67
(Figures in U.S. Dollars)
1 Week 4.6%   13 Weeks -13.8%  
4 Weeks -18.1%   52 Weeks -15.6%  
Adma Biologics Inc Key Data:
  Ticker: ADMA Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 16,985,290
(Year Ending Jan 2019).
Employees: 318
  Currency: U.S. Dollars Market Cap: 217,698,363
  Fiscal Yr Ends: December Shares Outstanding: 59,318,355
  Share Type: Common Closely Held Shares: 11,121,150
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.